Float Short %

1.41

Margin Of Safety %

-6

Put/Call OI Ratio

1.87

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.35

Price

79.8

Target Price

96.93

Analyst Recom

1.77

Performance Q

-5.07

Upside

-49.0%

Beta

0.94

Ticker: EW

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	EW	83.64	2.05	1.29	58201
2026-01-26	EW	84.29	2.04	2.60	58828
2026-01-27	EW	83.58	2.05	0.08	59883
2026-01-28	EW	81.84	2.00	0.49	60450
2026-01-29	EW	81.49	1.99	1.12	60544
2026-01-30	EW	81.37	1.99	7.38	60582
2026-02-02	EW	82.64	2.00	1.60	60780
2026-02-04	EW	79.72	2.03	3.40	61640
2026-02-05	EW	78.08	1.92	4.78	60886
2026-02-06	EW	78.68	2.15	2.18	68268
2026-02-09	EW	76.77	2.07	9.77	66782
2026-02-10	EW	77.04	2.18	1.39	69400
2026-02-11	EW	79.33	2.01	0.19	79394
2026-02-12	EW	76.41	2.01	0.08	79704
2026-02-13	EW	75.84	1.92	0.71	77985
2026-02-18	EW	78.98	1.87	0.16	78693
2026-02-19	EW	78.93	1.87	0.47	78808
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

17 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	EW	83.65	5.0	71.2	2.58
2026-01-26	EW	84.27	5.0	103.0	2.58
2026-01-27	EW	83.59	5.0	73.5	2.58
2026-01-28	EW	81.86	5.0	48.9	2.58
2026-01-29	EW	81.46	5.0	79.7	2.58
2026-01-30	EW	81.36	5.0	85.9	2.58
2026-02-02	EW	82.66	5.0	119.8	2.58
2026-02-03	EW	82.11	5.0	76.4	2.58
2026-02-04	EW	79.75	4.9	34.1	2.58
2026-02-05	EW	78.08	4.9	48.3	2.58
2026-02-06	EW	78.68	4.9	103.3	2.58
2026-02-09	EW	76.76	4.9	41.4	2.58
2026-02-10	EW	77.07	4.9	95.8	2.58
2026-02-12	EW	76.40	4.9	17.8	2.58
2026-02-18	EW	78.97	13.4	101.8	2.95
2026-02-19	EW	78.92	13.4	87.4	2.95
2026-02-20	EW	79.80	13.4	-	2.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

17 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	EW	-1.29	-0.18	1.25
2026-01-26	EW	-1.29	-0.08	1.25
2026-01-27	EW	-1.29	-0.08	1.25
2026-01-28	EW	-1.29	-0.08	1.38
2026-01-29	EW	-1.24	-0.08	1.38
2026-01-30	EW	-1.24	-0.08	1.38
2026-02-02	EW	-1.24	-0.30	1.38
2026-02-03	EW	-1.24	-0.30	1.38
2026-02-04	EW	-1.24	-0.30	1.38
2026-02-05	EW	-1.24	-0.30	1.38
2026-02-06	EW	-1.24	-0.30	1.38
2026-02-09	EW	-1.24	-1.62	1.38
2026-02-10	EW	-1.24	-1.62	1.38
2026-02-11	EW	-1.24	-1.62	1.41
2026-02-12	EW	-1.24	-1.62	1.41
2026-02-13	EW	-1.24	-1.62	1.41
2026-02-17	EW	-1.51	-0.47	1.41
2026-02-18	EW	-1.51	-0.47	1.41
2026-02-19	EW	-1.41	-0.47	1.41
2026-02-20	EW	-1.41	-0.47	1.41
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.73

Avg. EPS Est. Next Quarter

0.75

Insider Transactions

-1.41

Institutional Transactions

-0.47

Beta

0.94

Average Sales Estimate Current Quarter

1594

Average Sales Estimate Next Quarter

1682

Fair Value

75.14

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.4

Max Drawdown 5-Year %

-54.3

Target Price

96.93

P/E

43.06

Forward P/E

24.05

PEG

1.8

P/S

7.63

P/B

4.54

P/Free Cash Flow

57.57

EPS

1.85

Average EPS Est. Cur. Y

2.95

EPS Next Y. (Est.)

3.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.92

Relative Volume

1.23

Return on Equity vs Sector %

-15.6

Return on Equity vs Industry %

-4.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

Edwards Lifesciences Corporatio

Sector: Healthcare

Industry: Medical Devices

Employees:

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

stock quote shares EW – Edwards Lifesciences Corporation Stock Price stock today

news today EW – Edwards Lifesciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EW – Edwards Lifesciences Corporation yahoo finance google finance

stock history EW – Edwards Lifesciences Corporation invest stock market

stock prices EW premarket after hours

ticker EW fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y